Visual recovery following Mycobacterium chelonae endophthalmitis.
Following uncomplicated cataract surgery, a patient receiving etanercept for psoriatic arthritis developed Mycobacterium chelonae endophthalmitis. Vitrectomy, capsulectomy, and intraocular lens removal was followed by intravitreal amikacin, topical gatifloxacin, intravenous imipenem, and oral clarithromycin for six months. The patient achieved a final corrected visual acuity of 20/20. Etanercept has been implicated in the development of numerous, severe granulomatous infections, though not previously with M. chelonae. This represents the first reported case of visual recovery following M. chelonae endophthalmitis.
Stewart
Michael W
MW
Department of Ophthalmology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA. stewart.michael@mayo.edu
Alvarez
Salvador
S
Ginsburg
William W
WW
Shetty
Rajesh
R
McLain
Walter C
WC
Sleater
Joseph P
JP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D009877:Endophthalmitis / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D007908:Lens, Crystalline / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000382:microbiology / Q000503:physiopathology* / Q000628:therapy; D016926:Mycobacterium chelonae / Q000302:isolation & purification*; D020127:Recovery of Function / Q000502:physiology*; D014792:Visual Acuity / Q000502:physiology*; D014821:Vitrectomy
D000900:Anti-Bacterial Agents